These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8464317)

  • 21. Post-kala-azar dermal leishmaniasis.
    Ramesh V
    Australas J Dermatol; 1993; 34(1):35. PubMed ID: 8240186
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of molecular approaches to distinguish post kala-azar dermal leishmaniasis from leprosy: A case study.
    Roy S; Roy M; Nath S; Chaudhuri SJ; Ghosh MK; Mukherjee S; Chatterjee M
    Indian J Dermatol Venereol Leprol; 2023; 89(2):298-300. PubMed ID: 36461804
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.
    Das VN; Pandey K; Verma N; Bimal S; Lal CS; Singh D; Das P
    Natl Med J India; 2010; 23(2):88-9. PubMed ID: 20925205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis.
    Gasim S; Theander TG; ElHassan AM
    Acta Trop; 2000 Feb; 75(1):35-8. PubMed ID: 10708005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the differences between post-kala-azar dermal leishmaniasis and leprosy.
    Ramesh V
    Trop Doct; 1994 Jul; 24(3):120-1. PubMed ID: 8091519
    [No Abstract]   [Full Text] [Related]  

  • 27. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
    Islam S; Kenah E; Bhuiyan MA; Rahman KM; Goodhew B; Ghalib CM; Zahid MM; Ozaki M; Rahman MW; Haque R; Luby SP; Maguire JH; Martin D; Bern C
    Am J Trop Med Hyg; 2013 Aug; 89(2):345-53. PubMed ID: 23817330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve involvement in Indian post kala-azar dermal leishmaniasis.
    Khandpur S; Ramam M; Sharma VK; Salotra P; Singh MK; Malhotra A
    Acta Derm Venereol; 2004; 84(3):245-6. PubMed ID: 15202852
    [No Abstract]   [Full Text] [Related]  

  • 30. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.
    Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C
    Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid Multiplex Loop-Mediated Isothermal Amplification (m-LAMP) Assay for Differential Diagnosis of Leprosy and Post-Kala-Azar Dermal Leishmaniasis.
    Joshi S; Dixit KK; Sharma V; Ramesh V; Singh R; Salotra P
    Am J Trop Med Hyg; 2021 Apr; 104(6):2085-2090. PubMed ID: 33872215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India.
    Pandey K; Das VN; Singh D; Das S; Lal CS; Verma N; Bimal S; Topno RK; Siddiqui NA; Verma RB; Sinha PK; Das P
    J Clin Microbiol; 2012 Apr; 50(4):1478-9. PubMed ID: 22278840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh.
    Ghosh D; Sagar SK; Uddin MR; Rashid MU; Maruf S; Nath R; Islam MN; Aktaruzzaman MM; Sohel ANM; Banjara MR; Kroeger A; Aseffa A; Mondal D
    Int J Infect Dis; 2024 Oct; 147():107213. PubMed ID: 39179149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
    Ganguly S; Saha P; Chatterjee M; Roy S; Ghosh TK; Guha SK; Kundu PK; Bera DK; Basu N; Maji AK
    PLoS Negl Trop Dis; 2015; 9(10):e0004138. PubMed ID: 26485704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post kala-azar dermal leishmaniasis: the Kenyan experience.
    Muigai R; Gachihi GS; Oster CN; Were JB; Nyakundi PM; Chunge CN; Kirigi G; Rashid JR
    East Afr Med J; 1991 Oct; 68(10):801-6. PubMed ID: 1667521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-kala-azar dermal leishmaniasis: recent developments.
    Singh S; Sharma U; Mishra J
    Int J Dermatol; 2011 Sep; 50(9):1099-108. PubMed ID: 22126871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-kala-azar dermal leishmaniasis: a case report strikingly resembling lepromatous leprosy.
    Ramesh V; Saxena U; Misra RS; Mukherjee A
    Lepr Rev; 1991 Jun; 62(2):217-21. PubMed ID: 1651437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-kala-azar dermal leishmanasis occurring after 10 years of treated kala azar.
    Mittal R; Behl PN; Srivastava G
    Int J Dermatol; 2002 Dec; 41(12):875-6. PubMed ID: 12492974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.